Home

Bright Green Corporation - Common Stock (BGXX)

0.1481
0.00 (0.00%)

Bright Green Corporation is a biotechnology company specializing in the cultivation and production of cannabis for medicinal and research purposes

The company focuses on advancing the science of cannabis by leveraging state-of-the-art cultivation techniques and cutting-edge research to deliver high-quality, compliant products. Bright Green aims to support the healthcare industry by providing access to safe and effective cannabis treatments while also exploring new applications in various therapeutic areas. The organization is committed to sustainable practices and adheres to stringent regulatory standards to ensure the integrity and efficacy of its offerings.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close0.1481
Open-
Bid0.1550
Ask0.1580
Day's RangeN/A - N/A
52 Week Range0.1481 - 0.4390
Volume0
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume-

News & Press Releases

Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances
FORT LAUDERDALE, FLORIDA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) (“Bright Green” or the “Company”) announced that on February 24, 2025, on behalf of the Company, Lynn Stockwell has asked the court to approve the “RSA” Restructuring Security Agreement. The highlights of the RSA will provide new equity for the company to pay all creditors with approved claims in full, in addition the Company equity shareholders will retain their interests in the Company and are unimpaired with no dilution.
By Bright Green Corporation · Via GlobeNewswire · February 24, 2025
This Week In Cannabis: Paraguay Nears Adult-Use Sales, JPMorgan Hints At Banking And More On Earnings, NHL, Tyson, STIIIZY, Germanybenzinga.com
Cannabis news: Paraguay nears adult-use cannabis legalization, JPMorgan hints at cannabis banking, Germany's medical market booms and more!
Via Benzinga · January 31, 2025
Nasdaq-Traded Cannabis Producer Bright Green Corporation Faces Delisting, Focuses On Strategic Growthbenzinga.com
Bright Green Corporation addresses Nasdaq delisting, reinforces its commitment to shareholders, and outlines strategic partnerships and growth plans for the future.
Via Benzinga · September 23, 2024
Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Companybenzinga.com
Via Benzinga · August 22, 2024
BGXX Stock Earnings: Bright Green Reported Results for Q2 2024investorplace.com
Bright Green just reported results for the second quarter of 2024.
Via InvestorPlace · August 19, 2024
BGXX Stock Earnings: Bright Green Reported Results for Q1 2024investorplace.com
Bright Green just reported results for the first quarter of 2024.
Via InvestorPlace · May 20, 2024
BGXX Stock Earnings: Bright Green Reported Results for Q4 2023investorplace.com
Bright Green just reported results for the fourth quarter of 2023.
Via InvestorPlace · April 17, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 12, 2024
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Via Benzinga · June 7, 2024
Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 7, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · June 6, 2024
RJD Green Inc. (OTC: RJDG) Stock Surges Amid Investor Interest on Record Revenues
RJD Green Inc. (OTC: RJDG) captured significant investor attention, leading to a substantial stock gain of 29.5% on June 5, 2024. The trading volume surged to nine times the average daily volume. The company announced that its business unit, Silex Holdings Inc., achieved its highest monthly revenue since its establishment in June 2006. In May, Silex Holdings, Inc., a division of RJD Green, recorded $865,730 in revenues and a net operating profit of $242,404 . For context, the average annual revenue from Silex over the past two years was $4,800,000, with May 2024 revenues accounting for 18.1% of the annual income in 2023.
Via AB Newswire · June 6, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · June 5, 2024
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 5, 2024
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · June 5, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · June 3, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 3, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · May 31, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 31, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · April 26, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · April 11, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · March 22, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 14, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · March 13, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · March 12, 2024